Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Clicks: 245
ID: 117796
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
teague2019cancercheckpoint Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lindsey M. Kuehm,Kyle J. Wolf,John Zahour,Richard J. DiPaolo,Ryan M. Teague;Lindsey M. Kuehm;Kyle J. Wolf;John Zahour;Richard J. DiPaolo;Ryan M. Teague;
Journal cancer immunology, immunotherapy
Year 2019
DOI
10.1007/s00262-019-02346-4
URL
https://sciprofiles.com/publication/view/1feb5fda94ee6977e9c7462597b902eb
Keywords
melanoma immunotherapy t cell checkpoint blockade tcr diversity

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.